31 /100
MEDIUM RISK
Score updated May 30, 2026

TNYA — Tenaya Therapeutics, Inc. Dilution Risk Tracker

Track TNYA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TNYA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
38%
🔄 Reverse Split 55%
• 50-day avg $0.76 below $1 exchange minimum
📉 Score Deterioration 25%
• Score increased 13 points recently (worsening)
💰 Capital Raise 18%
• Active ATM program with $60M remaining capacity
🔔 Track TNYA — Get forecast alerts →

💹 Market Data

Market Cap$188.57M
Shares Outstanding217.00M
Float216.07M
Cash$80.89M
Debt$10.12M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 99.1% shares (2025Q4 vs prior)
97 institutional holders · 70.55M shares
#1 Column Group LLC 9.40M shares
#2 VANGUARD GROUP INC 8.56M shares
#3 Empery Asset Management, LP 5.41M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest28.75M
Days to Cover4.4
% of Float13.3%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
4 INSIDER TRANSACTION Feb 26, 2026
4 INSIDER TRANSACTION Feb 24, 2026
4 INSIDER TRANSACTION Feb 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track TNYA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TNYA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for TNYA
📊 TNYA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TNYA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.